1. Home
  2. Directory
  3. Louisiana
  4. Alexandria
  5. Internal Medicine
  6. NPI Profile
  7. Prescriptions 1982137543

DR. MUHAMMAD SIDDIQUE PIR M.D.
Prescription History 1982137543
Internal Medicine - Interventional Cardiology in Alexandria, LA

NPI Status: Active since April 10, 2017

Contact Information

3311 PRESCOTT RD
ALEXANDRIA, LA
ZIP 71301
Phone: (318) 767-3346

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MUHAMMAD SIDDIQUE PIR M.D., an active Interventional Cardiology specialist practicing in Alexandria, LA. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 88 documented patient claims. Among these therapy options, the most frequently utilized medication is Metoprolol Succinate, which accounts for 27 claims alone.

Medication Index

C
E
F
L
M
No matching medications currently found on file.

Carvedilol

Generic Formulation: CarvedilolSpecialty: Interventional Cardiology
Provider Metrics Summary
Total Claims 12
30-Day Fills 18.7
Days Supply 500
LA State Average Benchmarks
Peer Average Claims80.0
Peer Average 30-Day Fills165.5
Peer Average Days Supply4,902
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 85.0% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $53.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.43

State Avg Cost Per Claim

$9.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION.

Therapeutic Applications

Carvedilol is used to treat high blood pressure and heart failure. It is also used after a heart attack to improve the chance of survival if your heart is not pumping well. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect lowers your heart rate, blood pressure, and strain on your heart. Carvedilol belongs to a class of drugs known as alpha and beta blockers.

Entresto

Generic Formulation: Sacubitril/ValsartanSpecialty: Interventional Cardiology
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 565
LA State Average Benchmarks
Peer Average Claims67.0
Peer Average 30-Day Fills92.9
Peer Average Days Supply2,669
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 71.6% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,197.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$694.62

State Avg Cost Per Claim

$861.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product is used to treat certain types of heart failure. It may help you live longer and lower your chance of having to go to the hospital for heart failure. This product contains 2 medications: sacubitril and valsartan. Sacubitril belongs to a class of drugs called neprilysin inhibitors and valsartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). They work by relaxing blood vessels so that blood can flow more easily, which makes it easier for your heart to pump blood to your body.

Furosemide

Generic Formulation: FurosemideSpecialty: Interventional Cardiology
Provider Metrics Summary
Total Claims 18
30-Day Fills 25.5
Days Supply 765
LA State Average Benchmarks
Peer Average Claims98.0
Peer Average 30-Day Fills183.0
Peer Average Days Supply5,311
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 81.6% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $84.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.68

State Avg Cost Per Claim

$5.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.

Therapeutic Applications

Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.

Lisinopril

Generic Formulation: LisinoprilSpecialty: Interventional Cardiology
Provider Metrics Summary
Total Claims 12
30-Day Fills 28.0
Days Supply 840
LA State Average Benchmarks
Peer Average Claims108.0
Peer Average 30-Day Fills242.7
Peer Average Days Supply7,211
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 88.9% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $79.56 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.63

State Avg Cost Per Claim

$6.47

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.

Therapeutic Applications

Lisinopril is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily.

Metoprolol Succinate

Generic Formulation: Metoprolol SuccinateSpecialty: Interventional Cardiology
Provider Metrics Summary
Total Claims 27
30-Day Fills 42.0
Days Supply 1,110
LA State Average Benchmarks
Peer Average Claims122.0
Peer Average 30-Day Fills270.9
Peer Average Days Supply8,064
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 77.9% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $276.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.24

State Avg Cost Per Claim

$16.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Therapeutic Applications

This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. MUHAMMAD SIDDIQUE PIR M.D. provides transparency into local medical care patterns within Alexandria, LA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Interventional Cardiology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.